Pharmazone is a leading Consulting company with a strong legacy of trust amongst the global Pharmaceutical & Life Sciences industry. The company specializes in Regulatory Affairs, Pharmacovigilance, GxP Compliance solutions to clients for improving patient’s lives through unique Commit-Collaborate-Carry Model.
As a Regulatory Specialist, we assist our clients with solutions like Regulatory Intelligence & Strategy, Medical Writing, Submission & Publishing, Artwork, Labelling, translation, Health Authority interactions, and all post-approval requirements including an end to end Pharmacovigilance services like case management, Aggregate Reports, Signal Detection, MICC, etc. Our objective is to help large, medium & small-size life science companies in efficient execution & compliance of their drug development plans and Post-Approval Requirements for regulated markets and the developing world.
Global Regulatory Landscape is dynamic and our compliance services (GXP) play a vital role for clients. Being a trendsetter in GCP Auditing & Consulting, Pharmazone has successfully carried out 2000+ projects for Clinical Monitoring (Bioequivalence, Late Phase), Study Design, Audits, CRO setup & Up-gradation & Programme Management. Our GMP Solutions include Audits, Report Library, Quality Consulting, USFDA/EMA/PICS/WHO accreditation Support, CSV & Engineering Services including Plant Setup & Upgradation.
Though Client’s trust is our biggest recognition, our hard work-filled journey has brought us various awards like “Best HealthCare Brand” by CMO Asia -ABP News, “Top 10 Clinical Research Provider” by Silicon India.
“Value Creation by Right solutions” is Working Mantra at Pharmazone. The expert team at our global locations (INDIA, USA, CANADA and CHINA) have served 300+ Clients to satisfaction and we look forward to serving you!
regulatory affairs, gcp audits, gmp audits, cro set up, upgradation, pharmacovigilence, pharmaceutical plant set up, gmp engineering, clinical research monitoring, ectd, api audit report, bioequivalence monitoring, patient based study monitoring late phase phase ii, iii, publishing, submission, artwork, labelling, quality assurance, cmc services, pharmaceutical consulting